Search

Search results

24 results found

Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis

Hoeger, Christopher W, Arrush Choudhary, Andrea Nathalie Rosas Diaz, Theresa Pinto, Sarah Smalec, Charles Doladille, Rishi K. Wadhera, et al. 2025. “Cardiotoxicity of Combined Pegylated Liposomal Doxorubicin and Bevacizumab Therapy: A Propensity-Matched Cohort Study and Disproportionality Analysis”. BMC Cardio-Oncology.

Fellow Spotlight: Azariah Boyd

Azariah Boyd, MS is the 2024-2025 Joan and Marcel Zimetbaum Research Fellow at the Smith Center for Outcomes Research, working under the mentorship of Dr. Wadhera. She holds an MS in Environmental Health...

Report to the Congress: Medicare Payment Policy

"...Dual-eligible beneficiaries also have higher mortality rates, so their providers can have worse results on the discharge to community measure..." (Mortality and hospitalizations for dually enrolled and nondually enrolled Medicare beneficiaries aged 65 years or older, 2004 to 2017. JAMA 2020)